Royalty on Sales. 5.6.1 Subject to Article 5.6.2 and in further consideration of the rights and license granted to Acorda to the Elan Patent Rights while there is a Valid Claim thereunder, and in consideration of the rights and license granted to Acorda of the Elan Know-How thereafter, Acorda shall additionally pay to Elan a royalty of [***] of the NSP of the Product (the “Elan Royalty”). The Elan Royalty shall be payable as follows:
Appears in 6 contracts
Samples: License Agreement, License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)
Royalty on Sales. 5.6.1 Subject to Article 5.6.2 and in further consideration of the rights and license granted to Acorda to the Elan Patent Rights while there is a Valid Claim thereunder, and in consideration of the rights and license granted to Acorda of the Elan Know-How thereafter, Acorda shall additionally pay to Elan a royalty of [***] ten percent (10%) of the NSP of the Product (the “Elan Royalty”). The Elan Royalty shall be payable as follows:
Appears in 1 contract
